Home Featured

Featured

Here’s Why The Committee News Is So Important For GW Pharmaceuticals

ME Staff - April 23, 2018

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) Has More Upside Potential, Even After Gains

Neos Selloff Might Be An Opportunity For A Discount – Here’s Why

Here’s What You Need To Know About ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

Why No Rate Hike By The Fed Means They’re Asking For a Dollar Crisis

Today’s Movers and Shakers in Biotech

ME Contributor - December 2, 2015

Here’s What Just Happened With AstraZeneca plc (ADR) (NYSE:AZN), TESARO Inc...

ME Contributor - March 15, 2017

Coherus Biosciences Inc (NASDAQ:CHRS) Is Looking To Compete With Amgen, Inc....

ME Contributor - July 12, 2016

Market Morning: Musk Survives, China Throws Bone, Social Security Dries, Mexico...

ME Staff - June 6, 2018

TRACON Pharmaceuticals Inc (NASDAQ:TCON) Can Still Recover, Just Not With GBM

ME Contributor - February 10, 2017

INSYS is Targeting a $700 Million Market With Syndros

Jennifer Aldershot - November 30, 2015

Payrolls, Tariffs, Amazon Fights Seattle, and Nikola Challenges Tesla on Beer...

ME Staff - May 4, 2018

PhaseRx Inc (NASDAQ:PZRX): An Undervalued Rare Disease Play With Multiple Shots...

David Rich - September 30, 2016

A Clinical Hold Just Made Ionis Pharmaceuticals Inc (NASDAQ:IONS) Attractive. Here’s...

ME Staff - April 11, 2016

Biotech Movers: Insys Therapeutics Inc (NASDAQ:INSY) and Cempra Inc (NASDAQ:CEMP)

Jennifer Aldershot - July 5, 2016

12 3...88 Page 1 of 88

EDITOR PICKS

Crypto Daily Roundup: June 21

June 21, 2018

Market Morning: Fox Goes to Disney Land, OPEC Meeting Tomorrow

June 21, 2018

Market Morning: Chinese US Investment Collapses, Canadian Cannabis, GE Gets DOWnsized

June 20, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.